SEC Info - Ball David Edward - ‘4’ for 9/6/22 re: Avanos Medical, Inc.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Ball David Edward

(Last)

(First)

(Middle)

5405 WINDWARD PKWY

(Street)

ALPHARETTA

30004

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP - Global Supply Chain

3. Date of Earliest Transaction (Month/Day/Year)
09/06/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/06/2022		F		2,015 ⁽¹⁾	D	$23.87	11,968 ⁽²⁾	D
Common Stock	09/06/2022		F		733 ⁽³⁾	D	$23.87	11,235	D
Common Stock	09/06/2022		F		599 ⁽⁴⁾	D	$23.87	10,636	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the accelerated vesting of certain time-based restricted stock units ("TRSUs") granted to the Reporting Person on May 7, 2020. Pursuant to the terms of the Retention Incentive Agreement dated as of May 20, 2022 by and between the Issuer and the Reporting Person (the "Retention Incentive Agreement"), certain of the TRSUs granted to the Reporting Person on May 7, 2020, March 17, 2021 and March 4, 2022 vested upon the termination of the Reporting Person's employment with the Issuer on September 6, 2022.

2. Reflects the forfeiture of a total of 13,586 unvested TRSUs on September 6, 2022. Pursuant to the terms of the Retention Incentive Agreement, all the TRSUs granted on May 7, 2020, March 17, 2021 and March 4, 2022 that did not vest on September 6, 2022 as described in footnote 1 were forfeited. Such forfeited TRSUs were previously reported as beneficially owned in the Form 4s filed by the Reporting Person.

3. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the accelerated vesting, pursuant to the terms of the Retention Incentive Agreement, of certain TRSUs granted to the Reporting Person on March 17, 2021, as described in footnote 1.

4. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the accelerated vesting, pursuant to the terms of the Retention Incentive Agreement, of certain TRSUs granted to the Reporting Person on March 4, 2022, as described in footnote 1.

Remarks:

	/s/ Mojirade James, as attorney-in-fact for David E. Ball	09/08/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Ball David Edward – ‘4’ for 9/6/22 re: Avanos Medical, Inc.

On: Thursday, 9/8/22, at 5:11pm ET · For: 9/6/22 · As: Officer · Accession #: 1775747-22-3 · File #: 1-36440

Previous ‘4’: ‘4’ on 3/8/22 for 3/4/22 · Latest ‘4’: This Filing

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Ball David Edward – ‘4’ for 9/6/22 re: Avanos Medical, Inc.

On: Thursday, 9/8/22, at 5:11pm ET · For: 9/6/22 · As: Officer · Accession #: 1775747-22-3 · File #: 1-36440

Previous ‘4’: ‘4’ on 3/8/22 for 3/4/22 · Latest ‘4’: This Filing

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents